In the brain tumor, CD169+ macrophages expressed markers of monocyte-derived cells, such as CCR2 and Ly6C (Fig. 2g), although CD169 can be expressed in several tissue-resident macrophages. Here, SIGLEC1 is linked to brain neoplasm.